Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer.
暂无分享,去创建一个
F. Orsi | R. Orecchia | C. Garibaldi | G. Catalano | R. Cambria | F. Serafini | B. Jereczek-Fossa | D. Zerini | O. de Cobelli | A. Vavassori | L. Fariselli | L. Brait | M. Possanzini | L. Bianchi | G. Beltramo
[1] Nieves Calcerrada Díaz-Santos,et al. The safety and efficacy of robotic image-guided radiosurgery system treatment for intra- and extracranial lesions: a systematic review of the literature. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[2] S. Toms,et al. Stereotactic radiosurgical treatment of parenchymal brain metastases from prostate adenocarcinoma. , 2008, Surgical neurology.
[3] M. Røder,et al. The Early Prostate Cancer program: bicalutamide in nonmetastatic prostate cancer , 2008, Expert review of anticancer therapy.
[4] W. Lee,et al. Hypofractionation for prostate cancer: a critical review. , 2008, Seminars in radiation oncology.
[5] R. Orecchia,et al. Three-Dimensional Conformal or Stereotactic Reirradiation of Recurrent, Metastatic or New Primary Tumors , 2008, Strahlentherapie und Onkologie.
[6] R. Timmerman,et al. Stereotactic Body Radiation Therapy: A Comprehensive Review , 2007, American journal of clinical oncology.
[7] E. Wallen,et al. Androgen-Independent Prostate Cancer Treated with Resection of the Solitary Metastatic Site , 2007, Urologia Internationalis.
[8] Barbara Alicja Jereczek-Fossa,et al. Evidence-based radiation oncology: definitive, adjuvant and salvage radiotherapy for non-metastatic prostate cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] J. Fowler,et al. Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. , 2007, International journal of radiation oncology, biology, physics.
[10] Lei Xing,et al. Stereotactic body radiation therapy in multiple organ sites. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Steven D Chang,et al. Image-guided robotic radiosurgery for spinal metastases. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[12] T. Pawlicki,et al. Prostate cancer therapy with stereotactic body radiation therapy. , 2007, Frontiers of radiation therapy and oncology.
[13] M. Schwaiger,et al. The detection rate of [11C]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[14] K. Haustermans,et al. The role of whole pelvic radiotherapy in locally advanced prostate cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[15] Robert D Timmerman,et al. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. , 2006, Seminars in radiation oncology.
[16] R. Brasacchio,et al. Solitary metastases: illusion versus reality. , 2006, Seminars in radiation oncology.
[17] D. Weckermann,et al. Prostate Cancer Relapse after Therapy with Curative Intention: A Diagnostic and Therapeutic Dilemma , 2005, Oncology Research and Treatment.
[18] R. Miralbell,et al. Target repositioning optimization in prostate cancer: is intensity-modulated radiotherapy under stereotactic conditions feasible? , 2004, International journal of radiation oncology, biology, physics.
[19] E. B. Butler,et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. , 2004, JAMA.
[20] C. Brendler,et al. Return of serum prostate specific antigen to undetectable level following removal of solitary lymph node metastasis. , 2002, The Journal of urology.
[21] P. Fransson,et al. Prospective evaluation of urinary and intestinal side effects after BeamCath stereotactic dose-escalated radiotherapy of prostate cancer. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[22] M. Eto,et al. Surgical excision of a metastatic adrenal lesion in a patient with prostatic cancer , 1999, International journal of urology : official journal of the Japanese Urological Association.
[23] T. Pajak,et al. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.